HCPCS code J9359 — Inj lon tesirin-lpyl 0.075mg. Status: Active. Effective Apr 1, 2022. Source: CMS HCPCS Level II.

J9359

Active

Inj lon tesirin-lpyl 0.075mg

Injection, loncastuximab tesirine-lpyl, 0.075 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Apr 1, 2022
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9205

MUE — Medically Unlikely Edits

Maximum units of J9359 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 400
Practitioner Services 400

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
79952-0110-01 Zynlonta

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2022-Q2
    Inj lon tesirin-lpyl 0.075mg